Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer
Clinical trial NCT06513455 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06513455
- Sponsor
- Harbin Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2027-06-30
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.